Physician profile
Shawn Marhamati
NPI 1114312808
$129,703.32
in general payments reported to CMS, 2019-2025
11 companies · $98K in 2025
The $98K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $589 · 2022: $941 · 2023: $11K · 2024: $19K · 2025: $98K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $116K · Travel and Lodging: $8,636 · Food and Beverage: $3,531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $116,006.44 |
| Travel and Lodging | $8,636.06 |
| Food and Beverage | $3,530.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $126,836.32 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Angiodynamics, INC. | $1,274.17 | 2023-2025 | Nanoknife |
| Medtronic, INC. | $523.99 | 2021 | |
| Laborie Medical Technologies Corp. | $347.29 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Calyxo, INC. | $318.70 | 2025 | Cvac Aspiration System |
| Olympus America INC. | $205.74 | 2023-2025 | Itind System |
| Astellas Pharma US INC | $65.00 | 2021 | |
| Endo Pharmaceuticals INC. | $42.69 | 2022 | |
| Abbvie INC. | $33.17 | 2025 | |
| Sun Pharmaceutical Industries INC. | $32.34 | 2024 | |
| Pfizer INC. | $23.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Marhamati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.